To determine whether NETs associated with ALI in the lungs play a critical role in disease progression, we used a selective and effective inhibitor, GSK484, to block protein arginine deiminase 4 (PAD4), a key requirement for NET formation. The gene discussed is PADI4; the disease is acute respiratory distress syndrome.